Douglas Buckner Johnson
Vanderbilt University
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Inflammasome and immune disorders
Strong evidence · 1 supporting paper · latest 2026
Cancer Immunotherapy and Biomarkers
Solid evidence · 3 supporting papers · latest 2026
Melanoma and MAPK Pathways
Solid evidence · 1 supporting paper · latest 2026
Cutaneous Melanoma Detection and Management
Solid evidence · 2 supporting papers · latest 2026
Immunotherapy and Immune Responses
Supporting evidence · 1 supporting paper · latest 2026
interferon and immune responses
Supporting evidence · 1 supporting paper · latest 2026
Publications (5)
Tumor NLRP3 Amplification Promotes Immunotherapy Resistance by Inhibiting STAT1 Signaling and MHC Class I Expression
2026DOIPMID 42593864
Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti–PD-1 Therapy
2026DOIPMID 42335437
Clonal hematopoiesis is enriched in melanoma and associated with genotype-specific differences in tumor growth and survival
2026DOI
Spatial Transcriptomics of Immune Checkpoint Inhibitors Myocarditis
2026DOI
Spatial Transcriptomics of Immune Checkpoint Inhibitors Myocarditis
2026DOI
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Vanderbilt University
Source: OpenAlex · retrieved 2026-09-27